EarliPoint Health
Autism-diagnostics company commercializing an eye-tracking device that helps clinicians diagnose and assess autism earlier and more objectively.
Plymouth, MN
2019
11-50
$41M
Medicaid
What They Do
EarliPoint Health (formerly EarliTec Diagnostics) sells an FDA-cleared device that measures social visual engagement through eye tracking to support autism diagnosis and assessment in young children. Its model is provider-facing. The clearest publicly stated reimbursement signal is Georgia Medicaid coverage in 2024. The platform also functions as a longitudinal-outcomes tool.
Competitive Position
EarliPoint competes with Cognoa on autism diagnostics but takes a hardware-led rather than software-led approach. Eye-tracking is a distinct clinical modality from caregiver questionnaire and video-review tools, which positions EarliPoint for use cases where objective physiologic measurement is required.
Funding Rounds
No funding rounds on record for this company.